Display options
Cite
Witschkowski J, Behrends J, Frank R, et al. BCG Provides Short-Term Protection from Experimental Cerebral Malaria in Mice. Vaccines (Basel). 2020;8(4)doi: 10.3390/vaccines8040745.
Witschkowski, J., Behrends, J., Frank, R., Eggers, L., von Borstel, L., Hertz, D., Mueller, A. K., & Schneider, B. E. (2020). BCG Provides Short-Term Protection from Experimental Cerebral Malaria in Mice. Vaccines, 8(4), . https://doi.org/10.3390/vaccines8040745
Witschkowski, Julia, et al. "BCG Provides Short-Term Protection from Experimental Cerebral Malaria in Mice." Vaccines vol. 8,4 (2020). doi: https://doi.org/10.3390/vaccines8040745
Witschkowski J, Behrends J, Frank R, Eggers L, von Borstel L, Hertz D, Mueller AK, Schneider BE. BCG Provides Short-Term Protection from Experimental Cerebral Malaria in Mice. Vaccines (Basel). 2020 Dec 09;8(4). doi: 10.3390/vaccines8040745. PMID: 33316929; PMCID: PMC7768457.
Copy Download .nbib Format: NLM
Share it on

Vaccines (Basel). 2020 Dec 09;8(4). doi: 10.3390/vaccines8040745.

BCG Provides Short-Term Protection from Experimental Cerebral Malaria in Mice.

Vaccines

Julia Witschkowski, Jochen Behrends, Roland Frank, Lars Eggers, Linda von Borstel, David Hertz, Ann-Kristin Mueller, Bianca E Schneider

Affiliations

  1. Junior Research Group Coinfection, Priority Area Infections, Research Center Borstel-Leibniz Lung Center, 23845 Borstel, Germany.
  2. Core Facility Fluorescence Cytometry, Research Center Borstel-Leibniz Lung Center, 23845 Borstel, Germany.
  3. Centre for Infectious Diseases, Parasitology Unit, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  4. German Center for Infection Research (DZIF), TTU Malaria, 69120 Heidelberg, Germany.

PMID: 33316929 PMCID: PMC7768457 DOI: 10.3390/vaccines8040745

Abstract

Clinical and experimental evidence suggests that the tuberculosis vaccine BCG offers protection against unrelated pathogens including the malaria parasite. Cerebral malaria (CM) is the most severe complication associated with

Keywords: BCG; Plasmodium berghei ANKA; experimental cerebral malaria; heterologous immunity; non-specific protection

References

  1. Front Immunol. 2019 Apr 17;10:830 - PubMed
  2. Front Immunol. 2019 Jan 14;9:3157 - PubMed
  3. J Clin Invest. 2020 Oct 1;130(10):5591-5602 - PubMed
  4. Vaccine. 2000 Nov 22;19(7-8):779-87 - PubMed
  5. Sci Rep. 2018 Feb 15;8(1):3085 - PubMed
  6. J Neurosci Res. 2013 Oct;91(10):1292-302 - PubMed
  7. Proc Natl Acad Sci U S A. 1978 Oct;75(10):5142-4 - PubMed
  8. Int J Parasitol. 2011 Feb;41(2):155-63 - PubMed
  9. Front Immunol. 2018 Sep 10;9:2016 - PubMed
  10. PLoS One. 2011 Jan 31;6(1):e16610 - PubMed
  11. Front Immunol. 2018 Nov 13;9:2611 - PubMed
  12. Microcirculation. 2002 Dec;9(6):463-70 - PubMed
  13. Neurology. 1999 Oct 22;53(7):1588-9 - PubMed
  14. Neurobiol Dis. 2017 May;101:27-39 - PubMed
  15. EMBO Mol Med. 2013 Jul;5(7):984-99 - PubMed
  16. Expert Rev Vaccines. 2017 Jul;16(7):1-10 - PubMed
  17. PLoS One. 2010 Oct 01;5(10): - PubMed
  18. Vaccine. 2003 Jun 20;21(21-22):2782-90 - PubMed
  19. Front Immunol. 2018 Nov 29;9:2777 - PubMed
  20. Cell Host Microbe. 2018 Jan 10;23(1):89-100.e5 - PubMed
  21. J Infect Dis. 1978 May;137(5):550-5 - PubMed
  22. Infect Immun. 2005 Sep;73(9):5645-53 - PubMed
  23. Front Immunol. 2018 Dec 04;9:2869 - PubMed
  24. Proc Natl Acad Sci U S A. 1989 Jul;86(14):5572-4 - PubMed
  25. Nat Immunol. 2015 Jul;16(7):675-9 - PubMed
  26. Cell Microbiol. 2012 Mar;14(3):343-55 - PubMed
  27. Future Microbiol. 2018 Aug;13:1193-1208 - PubMed
  28. Scand J Immunol. 2004 Sep;60(3):273-7 - PubMed
  29. Neurology. 2014 Jan 7;82(1):41-8 - PubMed
  30. J Exp Med. 2002 May 20;195(10):1371-7 - PubMed
  31. Nature. 1976 Jan 29;259(5541):309-11 - PubMed
  32. Front Immunol. 2018 Feb 05;9:121 - PubMed
  33. BMC Res Notes. 2010 Apr 16;3:104 - PubMed
  34. Int J Epidemiol. 2005 Jun;34(3):540-7 - PubMed
  35. Nat Commun. 2019 Feb 20;10(1):874 - PubMed
  36. BMJ Glob Health. 2019 Nov 14;4(6):e001862 - PubMed
  37. Mol Immunol. 2015 Nov;68(1):40-4 - PubMed
  38. Trans R Soc Trop Med Hyg. 1982;76(3):410-5 - PubMed
  39. Infect Immun. 2014 Mar;82(3):1343-53 - PubMed
  40. Infect Immun. 1979 Jul;25(1):310-9 - PubMed
  41. J Immunol. 2002 Dec 1;169(11):6369-75 - PubMed
  42. Cell Host Microbe. 2011 May 19;9(5):355-61 - PubMed
  43. J Immunol. 2011 Jun 1;186(11):6148-56 - PubMed
  44. J Exp Med. 1969 May 1;129(5):1079-107 - PubMed
  45. J Infect Dis. 2011 Jul 15;204(2):245-52 - PubMed
  46. Infect Immun. 2015 Dec 07;84(2):502-10 - PubMed
  47. Front Cell Infect Microbiol. 2017 Jul 20;7:324 - PubMed
  48. Parasite Immunol. 2008 Jan;30(1):1-12 - PubMed
  49. J Immunol. 2012 Jul 15;189(2):968-79 - PubMed
  50. Virulence. 2012 Mar-Apr;3(2):193-201 - PubMed
  51. BMJ. 2004 Dec 4;329(7478):1309 - PubMed
  52. Infect Immun. 1981 Jul;33(1):199-211 - PubMed
  53. Infect Immun. 2010 Sep;78(9):4033-9 - PubMed
  54. Trends Parasitol. 2019 Jul;35(7):516-528 - PubMed
  55. Vaccine. 2014 Dec 5;32(51):6911-6918 - PubMed
  56. PLoS Negl Trop Dis. 2011 Mar 15;5(3):e985 - PubMed
  57. Eur J Immunol. 2000 Jun;30(6):1646-55 - PubMed
  58. Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17537-42 - PubMed
  59. PLoS One. 2013 Jul 04;8(7):e66115 - PubMed
  60. Expert Rev Vaccines. 2006 Apr;5(2):277-93 - PubMed
  61. PLoS Med. 2011 Mar;8(3):e1001012 - PubMed
  62. Infect Immun. 1981 Jan;31(1):408-12 - PubMed
  63. Nat Rev Immunol. 2018 Mar;18(3):153-167 - PubMed
  64. J Immunol. 1978 Oct;121(4):1257-61 - PubMed
  65. Pediatr Res. 2010 Oct;68(4):267-74 - PubMed
  66. BMJ. 2000 Dec 9;321(7274):1435-8 - PubMed

Publication Types

Grant support